Skip to content

In the BioHarmony Drug Report Database

Eflornithine

Ornidyl, Vaniqa (eflornithine) is a small molecule pharmaceutical. Eflornithine was first approved as Ornidyl on 1990-11-28. It is used to treat african trypanosomiasis, hypertrichosis, and protozoan infections in the USA. It has been approved in Europe to treat hirsutism. The pharmaceutical is active against ornithine decarboxylase.
Trade Name Vaniqa
Common Name Eflornithine
Indication african trypanosomiasis, hirsutism, hypertrichosis, protozoan infections
Drug Class Fc fusion protein
Eflornithine
Get full access now